as on February 5, 2026 at 4:07 pm IST
Day's High
2.64%
Upside
52 Week's Low
52 Week's High
11.35%
Downside
287.86%
Upside
as on February 5, 2026 at 10:37 am IST
Market Cap
₹66.08 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-2.71
Return on capital employed (ROCE)
0Industry PE ratio
41.03
Beta (LTM)
-2.28
P/B Ratio
0Dividend Yield
0PEG Ratio
-3.27
Quarterly Earnings Growth YOY
42.02
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
as on February 5, 2026 at 10:37 am IST
Vivimed Labs in the last 5 years
Lowest (-23.54x)
September 30, 2019
Today (-2.71x)
February 4, 2026
Industry (41.03x)
February 4, 2026
Highest (8.71x)
April 3, 2018
Today’s Price to Earnings Ratio: -2.71x
Compare market cap, revenue, PE, and other key metrics of Vivimed Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 66.08 | -10.28% | 1.02 | -32 | 116 | |
| NA | 644.95 | 28.85% | 0.69 | -44 | 340 | |
| NA | 161.87 | 2.71% | 0.00 | 5 | 97 | |
| BUY | 29,097.49 | 2.59% | 0.63 | 707 | 7,896 | |
| NA | 31.84 | -2.04% | 0.00 | 1 | 86 |
Get share price movements and forecasts by analysts on Vivimed Labs.
Source: S&P Global Market Intelligence
Search interest for Vivimed Labs Ltd Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:71% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Vivimed Labs.
Vivimed Labs Ltd’s net profit fell -42.02% since last year same period to ₹-7.30Cr in the Q2 2025-2026. On a quarterly growth basis, Vivimed Labs Ltd has generated -32.97% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2018, Vivimed Labs Ltd has declared dividend of ₹0.40 per share on 30 May 2018 - translating a dividend yield of 4.77%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 7.77% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 30.4% return, outperforming this stock by 98.9%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 162.1% return, outperforming this stock by 172.5%
FII Holding Unchanged
![]()
Foreign Institutions holdings remained unchanged at 1.64% of holdings in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 90.48% of holdings in Dec 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, -5.49 Cr → -7.3 Cr (in ₹), with an average decrease of 33.0% per quarter
Price Dip
![]()
In the last 1 month, VIVIMEDLAB stock has moved down by -38.4%
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 36.58 Cr → 20.82 Cr (in ₹), with an average decrease of 16.6% per quarter
| Organisation | Vivimed Labs Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Vivimed Labs share price today stands at ₹7.58 as on . Vivimed Labs share today touched a day high of ₹7.78 and a low of ₹7.58.
Vivimed Labs touched a 52 week high of ₹29.4 and a 52 week low of ₹6.72. Vivimed Labs share price today i.e. is trending at ₹7.58, which is -74.22% down from its 52 week high and 12.80% up from its 52 week low.
Vivimed Labs market capitalisation is ₹66.08 Cr as on .
To buy Vivimed Labs shares, you need to follow these steps:
Vivimed Labs trading volume is 1.76L as on . This means that 1.76L shares of Vivimed Labs were bought and sold on the stock market during today's trading session.